COGT
Cogent Biosciences Inc
31.00$
-1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | |
| – | – | – | – | 0.2% | 327.0% | – | – | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -227.0% | – | – | – | – | – | |
| 229.5% | 346.1% | 356.8% | 393.3% | 194.3% | 923.0% | – | – | – | – | – | |
| 91.3% | 54.0% | 56.0% | 76.6% | 48.7% | 221.3% | – | – | – | – | – | |
| 320.8% | 400.1% | 412.8% | 469.9% | 243.0% | 817.3% | – | – | – | – | – | |
| -220.8% | -300.1% | -312.8% | -369.9% | -143.0% | -1,044.3% | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.8% | – | – | – | – | – | |
| -220.8% | -285.2% | -304.9% | -354.8% | -141.5% | -950.4% | – | – | – | – | – | |
| – | -4.2% | -4.6% | 15.1% | -6.9% | -106.2% | – | – | – | – | – | |
| -220.8% | -285.2% | -304.9% | -354.8% | -134.6% | -950.4% | – | – | – | – | – | |
| -214.8% | -287.0% | -298.8% | -356.3% | -137.3% | -439.2% | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.